SUBSCRIBE TO OUR FREE NEWSLETTER
Daily news & progressive opinion—funded by the people, not the corporations—delivered straight to your inbox.
5
#000000
#FFFFFF
5
#000000
#FFFFFF
Bottles of a trial Covid-19 vaccine on a table in a lab in Brussels on June 18, 2020. (Photo: Vincent Kalut/Photonews via Getty Images)
Rich Nations Hoarding Potential Covid-19 Vaccine Doses, Warns Oxfam
"Governments will prolong this crisis in all of its human tragedy and economic damage if they allow pharmaceutical companies to protect their monopolies and profits."
Sep 17, 2020
Oxfam on Thursday reiterated its call for a "people's vaccine" as the anti-poverty group released a new analysis showing that a handful of rich nations representing just 13 percent of the world's population have snatched up over half of the promised Covid-19 vaccine doses.
"Access to a life-saving vaccine shouldn't depend on where you live or how much money you have," Robert Silverman, advocacy manager in Oxfam America's Private Sector department, said in a statement.
"The development and approval of a safe and effective vaccine is crucial," he said, "but equally important is making sure the vaccines are available and affordable to everyone."
\u201cUPDATE: A small group of rich nations - representing just 13% of world population - have bought up MORE THAN HALF the supply of leading #COVID19 vaccine contenders.\n\nTime for a #PeoplesVaccine - free for everyone, everywhere.\n\n\ud83d\udc49\ud83c\udffe https://t.co/rEBmLdd7h9\u201d— Oxfam International (@Oxfam International) 1600302600
In its findings, based on data from science analytics company Airfinity, Oxfam notes that nine vaccines are currently going through phase 3 clinical trials. Supply deals are known for five of those potential vaccines, and are being developed pharmaceutical giants by AstraZeneca, Gamaleya/Sputnik, Moderna, Pfizer and Sinovac.
The analysis comes amid swelling calls from global leaders, health experts, and groups including Oxfam for a so-called people's vaccine for the novel coronavirus. That effort would put the needs of public health above corporate profits and reject nationalist approaches towards vaccine acquisition.
According to Oxfam, out of supply deals inked for 5.3 billion doses, 51 percent--2.728 billion--were bought by wealthy nations including the U.K., U.S., Australia, Hong Kong and Macau, Japan, Switzerland, and Israel, and well as the European Union.
The group further warns that even if the five potential vaccines turn out to be sufficiently safe and effective--an unlikely scenario--the coming year would still be marked by the public health crisis because 61% of the world's population would likely not have a vaccine until at least 2022.
As Silverman noted in his statement, "Covid-19 anywhere is Covid-19 everywhere."
That simply underscores the need for a people's vaccine, says Chema Vera, interim executive director of Oxfam International.
"Governments will prolong this crisis in all of its human tragedy and economic damage if they allow pharmaceutical companies to protect their monopolies and profits," said Vera.
"No single corporation will ever be able to meet the world's need for a ovid-19 vaccine," he said, urging companies to "share their knowledge free of patents and to get behind a quantum leap in production to keep everyone safe."
"We need a people's vaccine, not a profit vaccine," Vera said.
An Urgent Message From Our Co-Founder
Dear Common Dreams reader, The U.S. is on a fast track to authoritarianism like nothing I've ever seen. Meanwhile, corporate news outlets are utterly capitulating to Trump, twisting their coverage to avoid drawing his ire while lining up to stuff cash in his pockets. That's why I believe that Common Dreams is doing the best and most consequential reporting that we've ever done. Our small but mighty team is a progressive reporting powerhouse, covering the news every day that the corporate media never will. Our mission has always been simple: To inform. To inspire. And to ignite change for the common good. Now here's the key piece that I want all our readers to understand: None of this would be possible without your financial support. That's not just some fundraising cliche. It's the absolute and literal truth. We don't accept corporate advertising and never will. We don't have a paywall because we don't think people should be blocked from critical news based on their ability to pay. Everything we do is funded by the donations of readers like you. Will you donate now to help power the nonprofit, independent reporting of Common Dreams? Thank you for being a vital member of our community. Together, we can keep independent journalism alive when it’s needed most. - Craig Brown, Co-founder |
Our work is licensed under Creative Commons (CC BY-NC-ND 3.0). Feel free to republish and share widely.
Oxfam on Thursday reiterated its call for a "people's vaccine" as the anti-poverty group released a new analysis showing that a handful of rich nations representing just 13 percent of the world's population have snatched up over half of the promised Covid-19 vaccine doses.
"Access to a life-saving vaccine shouldn't depend on where you live or how much money you have," Robert Silverman, advocacy manager in Oxfam America's Private Sector department, said in a statement.
"The development and approval of a safe and effective vaccine is crucial," he said, "but equally important is making sure the vaccines are available and affordable to everyone."
\u201cUPDATE: A small group of rich nations - representing just 13% of world population - have bought up MORE THAN HALF the supply of leading #COVID19 vaccine contenders.\n\nTime for a #PeoplesVaccine - free for everyone, everywhere.\n\n\ud83d\udc49\ud83c\udffe https://t.co/rEBmLdd7h9\u201d— Oxfam International (@Oxfam International) 1600302600
In its findings, based on data from science analytics company Airfinity, Oxfam notes that nine vaccines are currently going through phase 3 clinical trials. Supply deals are known for five of those potential vaccines, and are being developed pharmaceutical giants by AstraZeneca, Gamaleya/Sputnik, Moderna, Pfizer and Sinovac.
The analysis comes amid swelling calls from global leaders, health experts, and groups including Oxfam for a so-called people's vaccine for the novel coronavirus. That effort would put the needs of public health above corporate profits and reject nationalist approaches towards vaccine acquisition.
According to Oxfam, out of supply deals inked for 5.3 billion doses, 51 percent--2.728 billion--were bought by wealthy nations including the U.K., U.S., Australia, Hong Kong and Macau, Japan, Switzerland, and Israel, and well as the European Union.
The group further warns that even if the five potential vaccines turn out to be sufficiently safe and effective--an unlikely scenario--the coming year would still be marked by the public health crisis because 61% of the world's population would likely not have a vaccine until at least 2022.
As Silverman noted in his statement, "Covid-19 anywhere is Covid-19 everywhere."
That simply underscores the need for a people's vaccine, says Chema Vera, interim executive director of Oxfam International.
"Governments will prolong this crisis in all of its human tragedy and economic damage if they allow pharmaceutical companies to protect their monopolies and profits," said Vera.
"No single corporation will ever be able to meet the world's need for a ovid-19 vaccine," he said, urging companies to "share their knowledge free of patents and to get behind a quantum leap in production to keep everyone safe."
"We need a people's vaccine, not a profit vaccine," Vera said.
Oxfam on Thursday reiterated its call for a "people's vaccine" as the anti-poverty group released a new analysis showing that a handful of rich nations representing just 13 percent of the world's population have snatched up over half of the promised Covid-19 vaccine doses.
"Access to a life-saving vaccine shouldn't depend on where you live or how much money you have," Robert Silverman, advocacy manager in Oxfam America's Private Sector department, said in a statement.
"The development and approval of a safe and effective vaccine is crucial," he said, "but equally important is making sure the vaccines are available and affordable to everyone."
\u201cUPDATE: A small group of rich nations - representing just 13% of world population - have bought up MORE THAN HALF the supply of leading #COVID19 vaccine contenders.\n\nTime for a #PeoplesVaccine - free for everyone, everywhere.\n\n\ud83d\udc49\ud83c\udffe https://t.co/rEBmLdd7h9\u201d— Oxfam International (@Oxfam International) 1600302600
In its findings, based on data from science analytics company Airfinity, Oxfam notes that nine vaccines are currently going through phase 3 clinical trials. Supply deals are known for five of those potential vaccines, and are being developed pharmaceutical giants by AstraZeneca, Gamaleya/Sputnik, Moderna, Pfizer and Sinovac.
The analysis comes amid swelling calls from global leaders, health experts, and groups including Oxfam for a so-called people's vaccine for the novel coronavirus. That effort would put the needs of public health above corporate profits and reject nationalist approaches towards vaccine acquisition.
According to Oxfam, out of supply deals inked for 5.3 billion doses, 51 percent--2.728 billion--were bought by wealthy nations including the U.K., U.S., Australia, Hong Kong and Macau, Japan, Switzerland, and Israel, and well as the European Union.
The group further warns that even if the five potential vaccines turn out to be sufficiently safe and effective--an unlikely scenario--the coming year would still be marked by the public health crisis because 61% of the world's population would likely not have a vaccine until at least 2022.
As Silverman noted in his statement, "Covid-19 anywhere is Covid-19 everywhere."
That simply underscores the need for a people's vaccine, says Chema Vera, interim executive director of Oxfam International.
"Governments will prolong this crisis in all of its human tragedy and economic damage if they allow pharmaceutical companies to protect their monopolies and profits," said Vera.
"No single corporation will ever be able to meet the world's need for a ovid-19 vaccine," he said, urging companies to "share their knowledge free of patents and to get behind a quantum leap in production to keep everyone safe."
"We need a people's vaccine, not a profit vaccine," Vera said.
We've had enough. The 1% own and operate the corporate media. They are doing everything they can to defend the status quo, squash dissent and protect the wealthy and the powerful. The Common Dreams media model is different. We cover the news that matters to the 99%. Our mission? To inform. To inspire. To ignite change for the common good. How? Nonprofit. Independent. Reader-supported. Free to read. Free to republish. Free to share. With no advertising. No paywalls. No selling of your data. Thousands of small donations fund our newsroom and allow us to continue publishing. Can you chip in? We can't do it without you. Thank you.